[{"NetIncomeLoss_1_Q2_USD":-54581000.0,"DepreciationAndAmortization_2_Q2_USD":594000.0,"DepreciationAndAmortization_1_Q2_USD":300000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":19785000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":10042000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":26284000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":26323000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":42614000.0,"InterestPaidNet_2_Q2_USD":173000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-522000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":2250000.0,"AssetsCurrent_0_Q2_USD":438038000.0,"OperatingLeaseLiability_0_Q2_USD":6789000.0,"LongTermDebt_0_Q2_USD":15300000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-1583000.0,"ContractWithCustomerLiability_0_Q2_USD":27921000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":1242987.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":1011031.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":495000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":82000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":5000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":2185000.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":417000.0,"CommonStockSharesIssued_0_Q2_shares":26327000.0,"Assets_0_Q2_USD":448813000.0,"LongTermDebtCurrent_0_Q2_USD":5000000.0,"ShareBasedCompensation_2_Q2_USD":14527000.0,"EquityMethodInvestments_0_Q2_USD":920000.0,"Liabilities_0_Q2_USD":143165000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":95729000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":45679000.0,"EquityMethodInvestmentAggregateCost_0_Q2_USD":9200000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":7965000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":17727000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-878000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-520000.0,"AccountsReceivableNetCurrent_0_Q2_USD":2163000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":26000.0,"Dividends_2_Q2_USD":0.0,"ContractWithCustomerAssetNet_0_Q2_USD":2163000.0,"InterestExpenseLongTermDebt_1_Q2_USD":700000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":417000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-13000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":47094000.0,"ProceedsFromIssuanceOfDebt_2_Q2_USD":46599000.0,"DeferredRevenueNoncurrent_0_Q2_USD":9850000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-110927000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-54581000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-791000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":433574000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":5359000.0,"InterestExpenseLongTermDebt_2_Q2_USD":1300000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":6341000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q2_USD":7500000.0,"StockIssuedDuringPeriodValueAcquisitions_2_Q2_USD":5000000.0,"RestrictedCashNoncurrent_0_Q2_USD":107000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":-4128000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":920000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-328000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3657000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":1250000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":14527000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":7540000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-75893000.0,"DepositLiabilityCurrent_0_Q2_USD":10000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1987000.0,"CommonStockSharesOutstanding_0_Q2_shares":26327000.0,"LiabilitiesCurrent_0_Q2_USD":70769000.0,"AccountsPayableCurrent_0_Q2_USD":10084000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":433681000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":495000.0,"LongTermDebtNoncurrent_0_Q2_USD":56309000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.084,"AdditionalPaidInCapital_0_Q2_USD":560365000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":6550000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":101000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3407000.0,"NetIncomeLoss_2_Q2_USD":-110927000.0,"DeferredRevenueCurrent_0_Q2_USD":18071000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":38000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-29321000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-254743000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1176000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-468000.0,"PaymentsToAcquireInterestInJointVenture_2_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":60000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":4128000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2001000.0,"OperatingIncomeLoss_2_Q2_USD":-111386000.0,"OperatingIncomeLoss_1_Q2_USD":-53720000.0,"OperatingLeaseCost_2_Q2_USD":900000.0,"OperatingLeaseCost_1_Q2_USD":500000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":448813000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":5524000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14527000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7540000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":7064000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1430000.0,"OperatingExpenses_2_Q2_USD":115514000.0,"OperatingExpenses_1_Q2_USD":55721000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1828000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-4.22,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-2.07,"OtherLiabilitiesNoncurrent_0_Q2_USD":878000.0,"StockholdersEquity_0_Q2_USD":305648000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":522000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1022000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2699000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]